Sysmex (TSE:6869) Institutional Ownership : 12.51% (As of Apr. 29, 2024)

View and export this data going back to 1996. Start your Free Trial

What is Sysmex Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Sysmex's institutional ownership is 12.51%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Sysmex's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Sysmex's Float Percentage Of Total Shares Outstanding is 0.00%.

Sysmex Institutional Ownership Historical Data

The historical data trend for Sysmex's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sysmex Institutional Ownership Chart

Sysmex Historical Data

The historical data trend for Sysmex can be seen below:

	2023-06-30	2023-07-31	2023-08-31	2023-09-30	2023-10-31	2023-11-30	2023-12-31	2024-01-31	2024-02-29	2024-03-31
Institutional Ownership	9.83	9.86	9.78	9.70	9.66	9.67	9.67	9.77	9.81	12.51

Sysmex Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Sysmex (TSE:6869) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sysmex Corp (TSE:6869) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

SSMXY:USA SSMXF:USA 0YX:Germany

Address

1-5-1 Wakinohara-Kaigandori, Chuo-ku, Hyogo Prefecture, Kobe, JPN, 6510073

Website

http://www.sysmex.co.jp

Sysmex Corp manufactures and distributes in vitro diagnostic instruments, reagents, and software. The vast majority of the firm's revenue comes from selling tests for human bodily fluids to hospitals and commercial laboratories. Within this industry, the firm specializes in hematology reagents and instruments. Sysmex also sells in vitro diagnostics for applications like urinalysis and hemostasis and provides support and maintenance services for its systems. Over half of the firm's revenue is generated by sales of reagents and services, which are recurring sources of income. Sysmex primarily sells its products to customers in Japan, Europe, the Middle East, and Africa, and the Americas.

Sysmex (TSE:6869) Headlines

No Headlines